Literature DB >> 7507245

STK-1, the human homolog of Flk-2/Flt-3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitor/stem cells.

D Small1, M Levenstein, E Kim, C Carow, S Amin, P Rockwell, L Witte, C Burrow, M Z Ratajczak, A M Gewirtz.   

Abstract

We cloned the cDNA for stem cell tyrosine kinase 1 (STK-1), the human homolog of murine Flk-2/Flt-3, from a CD34+ hematopoietic stem cell-enriched library and investigated its expression in subsets of normal human bone marrow. The cDNA encodes a protein of 993 aa with 85% identity and 92% similarity to Flk-2/Flt-3. STK-1 is a member of the type III receptor tyrosine kinase family that includes KIT (steel factor receptor), FMS (colony-stimulating factor 1R), and platelet-derived growth factor receptor. STK-1 expression in human blood and marrow is restricted to CD34+ cells, a population greatly enriched for stem/progenitor cells. Anti-STK-1 antiserum recognizes polypeptides of 160 and 130 kDa in several STK-1-expressing cell lines and in 3T3 cells transfected with a STK-1 expression vector. Antisense oligonucleotides directed against STK-1 sequences inhibited hematopoietic colony formation, most strongly in long-term bone marrow cultures. These data suggest that STK-1 may function as a growth factor receptor on hematopoietic stem and/or progenitor cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7507245      PMCID: PMC42968          DOI: 10.1073/pnas.91.2.459

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Increasing specificity from the PCR-RACE technique.

Authors:  R Jain; R H Gomer; J J Murtagh
Journal:  Biotechniques       Date:  1992-01       Impact factor: 1.993

2.  Haematopoiesis. Multi-talented stem cells?

Authors:  M Dexter; T Allen
Journal:  Nature       Date:  1992 Dec 24-31       Impact factor: 49.962

Review 3.  Protein kinase classification.

Authors:  T Hunter
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

4.  Protein kinase catalytic domain sequence database: identification of conserved features of primary structure and classification of family members.

Authors:  S K Hanks; A M Quinn
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

5.  Acute- and chronic-phase chronic myelogenous leukemia colony-forming units are highly sensitive to the growth inhibitory effects of c-myb antisense oligodeoxynucleotides.

Authors:  M Z Ratajczak; N Hijiya; L Catani; K DeRiel; S M Luger; P McGlave; A M Gewirtz
Journal:  Blood       Date:  1992-04-15       Impact factor: 22.113

6.  Expression of the FMS/KIT-like gene FLT3 in human acute leukemias of the myeloid and lymphoid lineages.

Authors:  F Birg; M Courcoul; O Rosnet; F Bardin; M J Pébusque; S Marchetto; A Tabilio; P Mannoni; D Birnbaum
Journal:  Blood       Date:  1992-11-15       Impact factor: 22.113

7.  Murine Flt3, a gene encoding a novel tyrosine kinase receptor of the PDGFR/CSF1R family.

Authors:  O Rosnet; S Marchetto; O deLapeyriere; D Birnbaum
Journal:  Oncogene       Date:  1991-09       Impact factor: 9.867

8.  Role of the KIT protooncogene in normal and malignant human hematopoiesis.

Authors:  M Z Ratajczak; S M Luger; K DeRiel; J Abrahm; B Calabretta; A M Gewirtz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

9.  Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes.

Authors:  M Kozak
Journal:  Cell       Date:  1986-01-31       Impact factor: 41.582

Review 10.  Hematopoietic growth factors.

Authors:  M E Williams; P J Quesenberry
Journal:  Hematol Pathol       Date:  1992
View more
  77 in total

Review 1.  Novel agents for the treatment of childhood acute leukemia.

Authors:  Colleen E Annesley; Patrick Brown
Journal:  Ther Adv Hematol       Date:  2015-04

2.  Long-term culture system for selective growth of human B-cell progenitors.

Authors:  D J Rawlings; S G Quan; R M Kato; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

Review 3.  Molecular characterization of CD34+ human hematopoietic progenitor cells.

Authors:  W Knapp; H Strobl; C Scheinecker; C Bello-Fernandez; O Majdic
Journal:  Ann Hematol       Date:  1995-06       Impact factor: 3.673

4.  Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium.

Authors:  A L Petzer; D E Hogge; P M Landsdorp; D S Reid; C J Eaves
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

5.  TTT-3002 is a novel FLT3 tyrosine kinase inhibitor with activity against FLT3-associated leukemias in vitro and in vivo.

Authors:  Hayley Ma; Bao Nguyen; Li Li; Sarah Greenblatt; Allen Williams; Ming Zhao; Mark Levis; Michelle Rudek; Amy Duffield; Donald Small
Journal:  Blood       Date:  2014-01-09       Impact factor: 22.113

6.  miR-155 promotes FLT3-ITD-induced myeloproliferative disease through inhibition of the interferon response.

Authors:  Jared A Wallace; Dominique A Kagele; Anna M Eiring; Carissa N Kim; Ruozhen Hu; Marah C Runtsch; Margaret Alexander; Thomas B Huffaker; Soh-Hyun Lee; Ami B Patel; Timothy L Mosbruger; Warren P Voth; Dinesh S Rao; Rodney R Miles; June L Round; Michael W Deininger; Ryan M O'Connell
Journal:  Blood       Date:  2017-04-21       Impact factor: 22.113

Review 7.  Incorporating FLT3 inhibitors into acute myeloid leukemia treatment regimens.

Authors:  Keith Pratz; Mark Levis
Journal:  Leuk Lymphoma       Date:  2008-05

8.  RNA interference screen in primary human T cells reveals FLT3 as a modulator of IL-10 levels.

Authors:  Anne L Astier; Gaëlle Beriou; Thomas M Eisenhaure; Stephen M Anderton; David A Hafler; Nir Hacohen
Journal:  J Immunol       Date:  2009-12-16       Impact factor: 5.422

9.  The meaning of the c-kit proto-oncogene product in malignant transformation in human mammary epithelium.

Authors:  Chang Dae Ko; Jee Soo Kim; Byung Gyun Ko; Byung Ho Son; Hee Joon Kang; Ho Sung Yoon; Eun Yoon Cho; Gyungyub Gong; Sei Hyun Ahn
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

Review 10.  Potential role of sorafenib in the treatment of acute myeloid leukemia.

Authors:  Shahram Mori; Jorge Cortes; Hagop Kantarjian; Weiguo Zhang; Michael Andreef; Farhad Ravandi
Journal:  Leuk Lymphoma       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.